Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Sponsor
Asociación para Evitar la Ceguera en México
Study ID
NCT00804206
Phase
PHASE4
Status
Terminated

Conditions

  • Macular Edema

Eligibility Criteria

Sex
ALL
Age
40 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • bevacizumab — DRUG
    Intravitreal bevacizumab before panretinal photocoagulation
  • bevacizumab — DRUG
    Intravitreal Bevacizumab after panretinal photocoagulation

Study Details

Compare the effect of an intravitreal injection of bevacizumab previous or posterior of panretinal laser photocoagulation (PRLP) with a pattern laser; to prevent and reduce diabetic macular edema (DME) in patients with proliferative diabetic retinopathy (PDR) with DME.

Key Dates

First listed
Dec 8, 2008
Start date
Jul 31, 2008
Status verified
May 2024
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008

Study Design

Enrollment
15 participants (actual)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Group A
    Bevacizumab before panretinal photocoagulation.
  • Experimental: Group B
    Bevacizumab after panretinal photocoagulation

Primary Outcome Measure

Central macular thickness [ Time Frame: baseline, 10 days, 52 days, 85 days ]

Related Studies